ITMN - I was also surprised at the tone from ITMN's management. I realize they don't want to tick off the FDA or overpromise, but I can't believe they were not a little more upbeat after the advisory committee. They did everything to downplay the approval including reducing the size of the market opportunity.
I don't understand why they couldn't reveal how long it would take them to launch after approval or manufacture inventory. I've never seen a team so ill prepared for launch of a billion dollar drug. Sounds like it might take a year.
Market Data 
Markets 
AI
